Abbott Laboratories (ABT) Work In Process (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Work In Process data on file, last reported at $994.0 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 11.69% year-over-year to $994.0 million; the trailing twelve-month figure through Mar 2026 stood at $994.0 million (up 11.69% YoY), and the FY2025 full-year result was $904.0 million, up 7.62% from the prior year.
• Work In Process advanced to $994.0 million in Q1 2026, from $904.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $994.0 million in Q1 2026 to a low of $680.0 million in Q4 2022.
• A 5-year average of $843.8 million and a median of $877.0 million in 2024 frame the typical range for Work In Process.
• Across the five-year window, Work In Process dropped 10.8% in 2022 and increased 22.31% in 2023, its largest moves.
• Tracing ABT's Work In Process over 5 years: stood at $680.0 million in 2022, then climbed by 18.68% to $807.0 million in 2023, then climbed by 4.09% to $840.0 million in 2024, then climbed by 7.62% to $904.0 million in 2025, then rose by 9.96% to $994.0 million in 2026.
• Business Quant data shows ABT's Work In Process at $994.0 million in Q1 2026, $904.0 million in Q4 2025, and $961.0 million in Q3 2025.